Sulforaphane Supplements: Evidence, Forms, Dose, and Myrosinase

Sulforaphane is an isothiocyanate associated with broccoli, broccoli sprouts, and other cruciferous vegetables. The plant material commonly contains glucoraphanin, a glucosinolate precursor. When plant tissue is broken, the enzyme myrosinase can convert glucoraphanin into Sulforaphane.

Young broccoli sprouts can contain far more glucoraphanin than mature broccoli, but that finding is often retold incorrectly as a guaranteed Sulforaphane amount. Precursor content, conversion, and absorbed Sulforaphane are related measurements, not the same measurement. ¹

A fourth common presentation is a broccoli seed or sprout extract standardized to a stated Sulforaphane percentage. That label can disclose both the extract mass and the calculated Sulforaphane amount. The calculation is useful label arithmetic, but it is not independent confirmation of stability, conversion, or the content of the finished batch. If you are comparing a plain broccoli powder with a concentrated extract, see our guide to the difference between extracts and powders.

Sulforaphane is widely studied as an activator of the Nrf2 cellular-response pathway. Laboratory work helped establish how compounds can modify Keap1, a regulator that normally restrains Nrf2. This supports the mechanism, but it does not make Sulforaphane a genetic switch for longevity or prove that a supplement prevents disease. ²

A 12-week randomized trial in 291 adults exposed to substantial air pollution tested a specific broccoli sprout beverage. It increased urinary excretion of measured benzene and acrolein metabolites compared with placebo. The study measured defined exposure biomarkers from one beverage; it did not show that a capsule performs a general cleanse or removes every toxin. ⁵

Delivery format matters even when two preparations are intended to provide comparable Sulforaphane equivalents. In a small human feeding study, fresh sprouts produced about three times higher plasma and urinary Sulforaphane metabolite levels than the tested myrosinase-treated extract. That result belongs to those tested preparations and should not be turned into a rule that every sprout is better than every supplement. ⁴

Sulforaphane is not established as a cancer treatment. Research on cellular defenses, carcinogen metabolism, or prevention biomarkers does not show that a retail supplement treats an existing cancer. Anyone receiving cancer treatment should have a supplement reviewed by the oncology team rather than using a mechanism claim as medication clearance.

Sulforaphane has also been studied in autism spectrum disorder, but the clinical findings are mixed. A 2014 randomized trial in 44 young males reported improvements on several behavioral measures, while a later randomized trial in children did not find a significant treatment effect on its primary clinical outcome. A larger trial involving 108 children found improvement on clinician-rated measures but not on caregiver-rated scales. These studies used specific preparations and protocols and do not establish Sulforaphane as an autism treatment or predict whether an individual will benefit. ^{6, 10, 11}

Terms such as “activated,” “high potency,” “Nrf2 support,” and “broccoli complex” do not replace a named material and amount. A trademark can help identify a preparation, but it is not proof that every marketing claim has been demonstrated in the finished consumer product.

Sulforaphane, 10 mg per serving

The active compound and amount are directly stated. The label is clearer than a precursor-only claim, but it still cannot prove stability, actual finished-batch content, or personal benefit.

Broccoli sprout extract, 500 mg, standardized to 0.4% Sulforaphane

The label arithmetic gives 2 mg of declared Sulforaphane because 0.4% of 500 mg is 2 mg. The 500 mg extract mass should not be compared with 500 mg of Sulforaphane.

Glucoraphanin, 30 mg, with myrosinase

The precursor and enzyme are both visible, which is useful formulation context. Without a separate declared yield, the label still does not state how many milligrams of Sulforaphane the serving will produce or a person will absorb.

Organic broccoli powder, 500 mg

This states a food-derived powder amount, not a Sulforaphane dose. The label does not disclose glucoraphanin, active myrosinase, conversion yield, or direct Sulforaphane.

Human studies have used different preparations, including fresh sprouts, glucoraphanin-rich beverages, precursor plus myrosinase, and directly delivered Sulforaphane. The printed dose only makes sense when it remains attached to the tested material, serving basis, and outcome. A glucoraphanin dose cannot be copied into a direct Sulforaphane comparison as if conversion were complete.

Cutting or chewing raw cruciferous vegetables brings precursor and plant myrosinase together. Heating can reduce myrosinase activity, but cooked broccoli is not therefore worthless or guaranteed to produce zero Sulforaphane. Human work shows that conversion can still occur without active plant enzyme, though it is generally lower and more variable. ^{3 8}

Gastrointestinal adverse effects can occur with concentrated Sulforaphane preparations. In a seven-day randomized phase 1 study of the stabilized pharmaceutical formulation SFX-01 in healthy men, gastrointestinal events were common and were mostly mild. Because the study was short and tested one specific formulation, it does not establish a general side-effect rate, long-term safety, or a universal upper intake limit for Sulforaphane supplements. ⁹

A 12-week randomized study in 45 women found no measured adverse effect on thyroid-stimulating hormone, free thyroxine, thyroglobulin, or thyroid autoimmunity from the tested broccoli sprout beverage. That is reassuring for that protocol, but it does not prove that every extract, high dose, or long-term use is risk-free, and it does not justify self-prescribing iodine or selenium. ⁷

Pregnancy, breastfeeding, childhood use, active cancer treatment, thyroid disease, gastrointestinal conditions, and prescription medicine use deserve individual review by a clinician or pharmacist. A supplement label cannot provide complete interaction screening or decide personal suitability.

A label can disclose a direct Sulforaphane amount, glucoraphanin, a myrosinase source, extract mass, standardization percentage, expected yield, serving size, and blend structure. Those details make comparisons more precise.

The label alone cannot verify active myrosinase, actual conversion, Sulforaphane stability, finished-batch content, botanical identity, purity, contaminants, or storage quality. It also cannot prove a clinical outcome or determine whether the product is appropriate for one person.